ワクチンバイアルモニター市場：タイプ別、用途別-2025-2030年の世界予測

ワクチンバイアルモニター市場は、2023年に2億2,425万米ドルと評価され、2024年には2億7,538万米ドルに達すると予測され、CAGR 22.89%で成長し、2030年には9億4,927万米ドルに達すると予測されています。

ワクチンバイアルモニター（VVMs）は、ワクチンバイアルに装着する小型装置で、ワクチンが熱にさらされたかどうかを示すために色が変化し、効力に影響を与えます。VVMの必要性は、ワクチンの有効性を確実に維持するために、ワクチン流通におけるコールドチェーンを維持することが極めて重要であることに起因しています。最適な保管条件を維持することが課題となっている先進国、発展途上国のいずれにおいても、VVMの活用は不可欠です。エンドユーザーには主に、ヘルスケアプロバイダー、病院、診療所、政府の予防接種プログラムなどが含まれます。VVM市場の成長は、ワクチン接種キャンペーンの増加、ワクチンの効力の重要性に対する意識の高まり、モニター感度の技術的進歩の影響を受けています。さらに、予防接種プログラムに対する政府および非政府機関の支援が世界的に拡大していることも需要を後押ししています。しかし、VVM技術のコストが高いことや、一部の地域ではVVM技術の利点に関する認識が限定的であるなどの課題は、市場拡大に影響を及ぼす可能性があります。また、このようなモニターを広く利用できるようにするためには、一貫したサプライチェーンに依存する必要があるが、これは悪条件下では中断される可能性があります。

VVMの応用を他の感温性医薬品に拡大し、未開拓市場、特にヘルスケアインフラが脆弱な地域での普及を拡大する機会が存在します。企業は、リアルタイムのモニタリングとデータロギングを可能にするデジタル統合型VVMを開発することで、ワクチン流通網のより良い管理をサポートし、イノベーションを起こすことができます。VVMsのための、低コストだが同等の効果を持つ材料の調査は、製造コストの削減を助け、VVMsをより身近なものにする可能性があります。VVM市場の本質は競争であり、ハイテク企業とヘルスケア・プロバイダーが協力して機器の機能を強化する余地があります。企業は、利害関係者の知識を向上させるトレーニング・プログラムに投資したり、パートナーシップを活用して販売チャネルを強化したりすることで、戦略的に拡大することができます。

市場力学：急速に進化するワクチンバイアルモニター市場の主要市場インサイトを公開

ワクチンバイアルモニター市場は、需給要因のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ワクチンの安全投与に対する需要と重要性
  • ワクチンバイアルの適切なモニタリングの必要性
  • 感染症の高い流行と予防接種を推進する取り組みの増加
• 市場抑制要因
  • アプリケーションやロジスティクスに関する問題
• 市場機会
  • ワクチンバイアルモニターとコールドチェーンインフラの関係
  • 遠隔地における医療サービスの利便性向上に向けたヘルスケアセクターの取り組みの増加
• 市場の課題
  • VVMに対する規制上の慎重な検討

ポーターの5つの力：ワクチンバイアルモニター市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ワクチンバイアルモニター市場における外部からの影響の把握

外部マクロ環境要因は、ワクチンバイアルモニター市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ワクチンバイアルモニター市場における競合情勢の把握

ワクチンバイアルモニター市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスワクチンバイアルモニター市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ワクチンバイアルモニター市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ワクチンバイアルモニター市場における成功への道筋を描く

ワクチンバイアルモニター市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ワクチンの投与の需要と安全な使用の重要性
    • ワクチンバイアルの適切な監視の必要性
    • 感染症の蔓延と予防接種促進の取り組みの増加
  • 抑制要因
    • アプリケーションおよびロジスティクスに関連する問題
  • 機会
    • ワクチンバイアルモニターとコールドチェーンインフラの関係
    • 遠隔地における医療サービスのアクセス性向上に向けたヘルスケア分野の取り組みの強化
  • 課題
    • VVMに対する厳しい規制上の考慮
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ワクチンバイアルモニター市場：タイプ別

• マルチドーズ
• 単回投与

第7章 ワクチンバイアルモニター市場：用途別

• 予防ワクチン
• 治療ワクチン

第8章 南北アメリカのワクチンバイアルモニター市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のワクチンバイアルモニター市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのワクチンバイアルモニター市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Cardinal Health, Inc.
• Catalent, Inc.
• Corning Incorporated
• DWK Life Sciences GmbH
• Elitech Technology, Inc.
• ELPRO-BUCHS AG
• EVIGENCE SENSORS Inc.
• Gerresheimer AG
• Lisaline Lifescience Technologies Pvt Ltd.
• Nipro Corporation
• Pacific Vial Manufacturing Inc.
• Schott AG
• Stevanato Group
• Temptime Corporation by Zebra Technologies Corporation
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. VACCINE VIAL MONITOR MARKET RESEARCH PROCESS
• FIGURE 2. VACCINE VIAL MONITOR MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. VACCINE VIAL MONITOR MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. VACCINE VIAL MONITOR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VACCINE VIAL MONITOR MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VACCINE VIAL MONITOR MARKET DYNAMICS
• TABLE 7. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MULTI-DOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PREVENTIVE VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 16. ARGENTINA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. BRAZIL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. MEXICO VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 27. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. AUSTRALIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CHINA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CHINA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. INDIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. INDIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. INDONESIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. JAPAN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. MALAYSIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. PHILIPPINES VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. SINGAPORE VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. SOUTH KOREA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. TAIWAN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. THAILAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. VIETNAM VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. DENMARK VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. EGYPT VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. FINLAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. FRANCE VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. GERMANY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. ISRAEL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. ITALY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ITALY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. NETHERLANDS VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. NIGERIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. NORWAY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. POLAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. POLAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. QATAR VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. QATAR VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. RUSSIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SAUDI ARABIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SPAIN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SWEDEN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SWITZERLAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. TURKEY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. UNITED ARAB EMIRATES VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. UNITED KINGDOM VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. VACCINE VIAL MONITOR MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 100. VACCINE VIAL MONITOR MARKET, FPNV POSITIONING MATRIX, 2023

The Vaccine Vial Monitor Market was valued at USD 224.25 million in 2023, expected to reach USD 275.38 million in 2024, and is projected to grow at a CAGR of 22.89%, to USD 949.27 million by 2030.

Vaccine Vial Monitors (VVMs) are small devices attached to vaccine vials that change color to indicate whether the vaccine has been exposed to heat, thus affecting its potency. The need for VVMs stems from the critical requirement to maintain the cold chain in vaccine distribution to ensure vaccines remain effective. Their application is essential in both developed and developing regions, where maintaining optimal storage conditions is challenging. End-users predominantly include healthcare providers, hospitals, clinics, and government immunization programs. The growth of the VVM market is influenced by increasing vaccination campaigns, rising awareness on the importance of vaccine potency, and technological advancements in monitor sensitivity. Additionally, growing governmental and non-governmental support for immunization programs globally has driven demand. However, challenges such as the high cost of VVM technology and limited awareness about their benefits in some regions may affect market expansion. There is also a reliance on consistent supply chains to ensure the widespread availability of such monitors, which can be disrupted in adverse conditions.

Opportunities exist in expanding the application of VVMs to other temperature-sensitive pharmaceuticals and increasing penetration in untapped markets, particularly in regions with weaker healthcare infrastructures. Companies can innovate by developing VVMs with digital integration to allow real-time monitoring and data logging, which would support better management of vaccine distribution networks. Research into lower-cost but equally effective materials for VVMs may aid in reducing manufacturing costs, making them more accessible. The nature of the VVM market is competitive, with room for collaboration between tech firms and healthcare providers to enhance device features. Businesses can strategically expand by investing in training programs to improve stakeholder knowledge and by leveraging partnerships to strengthen distribution channels, catering particularly to regions with extreme temperature conditions where the demand for VVMs is crucial.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vaccine Vial Monitor Market

The Vaccine Vial Monitor Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Demand for administration and importance to the safe use of the vaccines
  • Need for adequate monitoring of vaccine vials
  • High prevalence of infectious diseases and a growing number of initiatives to promote immunization
• Market Restraints
  • Issues associated with applications, and logistics
• Market Opportunities
  • Relationship between vaccine vial monitors and cold chain infrastructure
  • Increasing healthcare sector efforts towards improving accessibility of medical services in remote areas
• Market Challenges
  • Stingent regulatory consideration for VVM

Porter's Five Forces: A Strategic Tool for Navigating the Vaccine Vial Monitor Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vaccine Vial Monitor Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vaccine Vial Monitor Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vaccine Vial Monitor Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vaccine Vial Monitor Market

A detailed market share analysis in the Vaccine Vial Monitor Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vaccine Vial Monitor Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vaccine Vial Monitor Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vaccine Vial Monitor Market

A strategic analysis of the Vaccine Vial Monitor Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vaccine Vial Monitor Market, highlighting leading vendors and their innovative profiles. These include Cardinal Health, Inc., Catalent, Inc., Corning Incorporated, DWK Life Sciences GmbH, Elitech Technology, Inc., ELPRO-BUCHS AG, EVIGENCE SENSORS Inc., Gerresheimer AG, Lisaline Lifescience Technologies Pvt Ltd., Nipro Corporation, Pacific Vial Manufacturing Inc., Schott AG, Stevanato Group, Temptime Corporation by Zebra Technologies Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Vaccine Vial Monitor Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Multi-Dose and Single Dose.
• Based on Application, market is studied across Preventive Vaccine and Therapeutic Vaccine.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Demand for administration and importance to the safe use of the vaccines
    • 5.1.1.2. Need for adequate monitoring of vaccine vials
    • 5.1.1.3. High prevalence of infectious diseases and a growing number of initiatives to promote immunization
  • 5.1.2. Restraints
    • 5.1.2.1. Issues associated with applications, and logistics
  • 5.1.3. Opportunities
    • 5.1.3.1. Relationship between vaccine vial monitors and cold chain infrastructure
    • 5.1.3.2. Increasing healthcare sector efforts towards improving accessibility of medical services in remote areas
  • 5.1.4. Challenges
    • 5.1.4.1. Stingent regulatory consideration for VVM
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Vaccine Vial Monitor Market, by Type

• 6.1. Introduction
• 6.2. Multi-Dose
• 6.3. Single Dose

7. Vaccine Vial Monitor Market, by Application

• 7.1. Introduction
• 7.2. Preventive Vaccine
• 7.3. Therapeutic Vaccine

8. Americas Vaccine Vial Monitor Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Vaccine Vial Monitor Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Vaccine Vial Monitor Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Cardinal Health, Inc.
• 2. Catalent, Inc.
• 3. Corning Incorporated
• 4. DWK Life Sciences GmbH
• 5. Elitech Technology, Inc.
• 6. ELPRO-BUCHS AG
• 7. EVIGENCE SENSORS Inc.
• 8. Gerresheimer AG
• 9. Lisaline Lifescience Technologies Pvt Ltd.
• 10. Nipro Corporation
• 11. Pacific Vial Manufacturing Inc.
• 12. Schott AG
• 13. Stevanato Group
• 14. Temptime Corporation by Zebra Technologies Corporation
• 15. Thermo Fisher Scientific Inc.